Glucose promotes breast cancer aggression and reduces metformin efficacy. - Wikidata - awgldk - TriplyDB

Glucose promotes breast cancer aggression and reduces metformin efficacy.

Glucose promotes breast cancer aggression and reduces metformin efficacy.

http://www.wikidata.org/entity/Q37525828

about

Glucose metabolism in gastric cancer: The cutting-edge Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation.Hyperglycemia, a neglected factor during cancer progression Effect of genetic variants and traits related to glucose metabolism and their interaction with obesity on breast and colorectal cancer risk among postmenopausal women.Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.TAp73 promotes anti-senescence-anabolism not proliferation.Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current Tumor mechanics and metabolic dysfunction.Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial Cells Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells.The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug Metformin and cancer: Quo vadis et cui bono?Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.Glucose-deprivation increases thyroid cancer cells sensitivity to metformin.Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.Essential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism.Recent advances in the use of metformin: can treating diabetes prevent breast cancer?Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach.Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models.Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.Pleiotropic Effects of Metformin on Cancer

P2860

Q26766098-9492286B-FB59-44FD-8F14-527B866E09BE Q28551723-9ABAB6AD-16B1-431E-BE0F-1BC459A37414 Q33577449-EE5000A7-96A8-465E-9229-3E86C6AF6432 Q33594115-B70FF296-79EC-4AA9-80A2-4C1ED1996AF6 Q33604592-D9FC765D-8BA7-4C31-B0E7-873C02A6DD4D Q33866151-4FF72BDF-A601-41B1-9095-E53ADCFDCE28 Q34774270-C1D89BBA-6FC9-46D6-989D-55A461C2C0B7 Q34957274-2138862A-5405-4B55-908F-594AF91728A1 Q35117423-5AF45759-EAA2-4F5B-B540-D8BB24058240 Q35751116-C1B9D7DB-5A8B-4946-9940-F2A27AC94F0A Q36062114-A4AF591F-2634-49FA-A438-BA420BB25CB1 Q36327268-93D65975-D01D-4FF0-94DF-A534DDB03C60 Q36414231-025E3728-05B6-446A-85CD-4013D8847705 Q36736195-55FC4842-D27A-4CAC-8818-2EEBE8BFB33B Q36952559-49B778FC-7200-49CC-9080-9A414ED4EFD0 Q37501673-86F0097A-4751-4646-AC0A-EB722DFC6F4E Q37688014-B105CD46-5C1F-478E-86BC-131A9140B0E2 Q38590960-9AE39F7F-0EED-48E7-ABDB-9E0157F1967E Q38693843-CDF0CDA9-0D24-4328-AC34-53FF143F6B59 Q38790790-D95B8CE9-355A-4B9E-93FC-BC1A26CB741C Q38829871-718CFD3E-27CB-49E6-9C7A-F7654D8410AF Q38835936-DB3FA69A-C0BC-4BD5-847C-A92654A324EF Q39030844-3E09E30F-AF26-409F-9C1C-2F2E536A580B Q40950194-6F570A84-D00A-4614-BF9D-86E7F4E718C2 Q41083568-4E44F3AF-3575-4679-8007-60F1A2B6D89D Q42265576-494897B7-63D1-4E62-AC4F-5467CA6E1C51 Q44670997-0C3D6462-3A26-4535-8115-9E3715727A06 Q48096856-2B148ECA-FC64-408C-B738-D7ED1015FB2E Q49197891-1B0C98D0-45E3-4487-8BB5-EE085B66C69A Q50098159-793C6DE3-6E87-437F-966C-11AB190312CF Q50585983-0779C0C7-42A3-494F-B599-2A7F2FA1E928 Q54109544-E3EE2F2F-3A72-4A62-B24E-EE12744D0F34 Q59138314-D1691D49-DEA6-49E9-9932-E380748992B2

P2860

Glucose promotes breast cancer aggression and reduces metformin efficacy.

http://www.wikidata.org/entity/Q37525828

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Glucose promotes breast cancer aggression and reduces metformin efficacy.

@en

Glucose promotes breast cancer aggression and reduces metformin efficacy.

@nl

type

label

Glucose promotes breast cancer aggression and reduces metformin efficacy.

@en

Glucose promotes breast cancer aggression and reduces metformin efficacy.

@nl

prefLabel

Glucose promotes breast cancer aggression and reduces metformin efficacy.

@en

Glucose promotes breast cancer aggression and reduces metformin efficacy.

@nl

P1433

Q37525828-89668C74-3B74-4360-B45B-0586944D0937

P1476

Q37525828-EA5958FD-861F-479E-80AD-9DF62BF5A07F

P2093

Q37525828-44196DEF-CE04-4545-BF34-52E2A363EADE

Q37525828-71E54148-10DB-4955-BEA4-3E4CD95E7E70

Q37525828-C4B62F87-9BCB-4F44-A488-ED589234DEED

Q37525828-DAD17660-DD38-42EA-8FBE-3902EB3CD666

Q37525828-DD471A86-7E88-4D0F-95A0-CED54A1E2F99

Q37525828-F331D437-1077-4905-A543-13F733ACA412

Q37525828-F75E30D9-8D08-4A3E-9B3C-BA9D46460AA8

P2860

Q37525828-02D48BEE-96BD-4E7E-9F3B-280D6AC36C5B

Q37525828-045205AA-1876-4522-B692-513265E220A3

Q37525828-05F103DE-070E-4577-A48E-1B5C1247FC87

Q37525828-06E06FCA-3CC3-4006-9E8C-6747D890285B

Q37525828-08AA6C8A-BA4C-4782-9D6E-B2A37E5C3A19

Q37525828-0E024E4B-9486-479E-B5E1-38877F810EBC

Q37525828-12035567-4AFF-42F6-BB6A-C3A750AA5F93

Q37525828-13942F9C-61DA-47B0-B240-11334909D8B5

Q37525828-2E5FE1F4-CE56-4C9B-91C4-CED86EED7E44

Q37525828-31B54134-979B-41FC-B2CE-384117018F3C

P304

Q37525828-D4074C4F-16DB-497B-8923-FAFCD0D89BBD

P31

Q37525828-9353D261-7E2A-4DE4-BA07-865103F48216

P356

Q37525828-D0BC0A7A-AC67-4D9B-AC19-B842B05C71EE

P433

Q37525828-62F3EB22-FF95-4E28-956B-42BA594DB96D

P478

Q37525828-E69411C4-5C8C-4BD8-9092-65F77427375F

P50

Q37525828-0B032609-8015-42B1-B3B0-B24B730F7F34

Q37525828-DF0C0E14-463E-49A9-B8F8-707AB863A763

P577

Q37525828-374B93E8-6170-43EE-9207-3D44A7DEE995

P5875

Q37525828-CA4D75E6-F172-4942-9A97-3C60EAF36CBE

P698

Q37525828-96CB147E-1211-4F36-9313-1AC2BCA58799

P921

Q37525828-86531ed0-d14f-44cc-9b35-82da1213e9a7

Q37525828-8981B414-E4F3-4DB2-BBC5-59306663AFA8

Q37525828-CC0E94F2-88A9-4263-BF9C-F9AB0E10CF0C

P932

Q37525828-F1477456-35E2-4670-B759-626505D02EDC

P356

P1433

P1476

Glucose promotes breast cancer aggression and reduces metformin efficacy

@en

P2093

Ann D Thor

http://www.w3.org/2001/XMLSchema#string

Jennifer K Richer

http://www.w3.org/2001/XMLSchema#string

Reema Wahdan-Alaswad

http://www.w3.org/2001/XMLSchema#string

Steven M Anderson

http://www.w3.org/2001/XMLSchema#string

Susan M Edgerton

http://www.w3.org/2001/XMLSchema#string

Xin-Sheng Deng

http://www.w3.org/2001/XMLSchema#string

Zeying Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Brick by brick: metabolism and tumor cell growth

Investigating metformin for cancer prevention and treatment: the end of the beginning

Metformin in cancer: translational challenges

On the Origin of Cancer Cells

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Metformin in breast cancer: time for action

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Metformin and reduced risk of cancer in diabetic patients

P304

3759-3769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.26641

http://www.w3.org/2001/XMLSchema#string

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Sigrid S Árnadóttir

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257598350

http://www.w3.org/2001/XMLSchema#string

P698

24107633

http://www.w3.org/2001/XMLSchema#string

P921

P932

3905068

http://www.w3.org/2001/XMLSchema#string